Sandra Van Lint

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Dendritic Cells

Top Venues

Nature communications

Molecular cancer

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Bram Van Den Eeckhout, Leander Huyghe, Sandra Van Lint, Elianne Burg, Stéphane Plaisance, Frank Peelman, Anje Cauwels, Gilles Uzé, Niko Kley, Sarah Gerlo, Jan Tavernier
Selective IL-1 activity on CD8 + T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication. Journal for immunotherapy of cancer 9 (11) (2022)
Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Vermaelen, Karine Breckpot, Sandra Van Lint
mRNA in cancer immunotherapy: beyond a source of antigen. Molecular cancer 20 (1) (2021)
Bram Van Den Eeckhout, Lien Van Hoecke, Elianne Burg, Sandra Van Lint, Frank Peelman, Niko Kley, Gilles Uzé, Xavier Saelens, Jan Tavernier, Sarah Gerlo
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant. NPJ vaccines 5 (1) (2020)
Lien Van Hoecke, Sandra Van Lint, Kenny Roose, Alexander Van Parys, Peter Vandenabeele, Johan Grooten, Jan Tavernier, Stefaan De Koker, Xavier Saelens
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes. Nature communications 9 (1) (2018)